Fake UK drug dealer caught by Eli Lilly could face 10 years prison
A counterfeit drug supplier based in Slough, UK, who was caught selling fake products to undercover agents from US drug major Eli Lilly, has pleaded guilty and awaits sentencing on July 28 at Reading Crown Court.
Mohammed Azim Dad pleaded guilty to three counts under the Trade Marks Act relating to fake erectile dysfunction drugs Eli Lilly's Cialis (tadalfil), German drug major Bayer's Levitra (vardenafil HCl) and global giant Pfizer's Viagra (sildenafil citrate).
Mr Dad admitted to buying fake Viagra and Cialis from a source in China, before selling them on the Internet auction web site eBay for L4 each ($7.38). He also claimed to have sold approximately L20,000 worth of ED drugs, which tests showed did not contain the correct doses of active ingredients.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze